Summit Trail Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Summit Trail Advisors’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-147,658	Closed	-$20.7K	–	682
2024 Q1	$20.7K	Buy	+147,658	New	+$29.1K	﹤0.01%	605

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Summit Trail Advisors's GRTX Position: Q2 2024 in Review

Summit Trail Advisors sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 147,658 shares — an estimated $20.7K sold.

Summit Trail Advisors first reported a position in GRTX in Q1 2024 and held it in 1 quarter. The position peaked at $20.7K in Q1 2024. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Summit Trail Advisors reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Summit Trail Advisors sold 147,658 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $20.7K.
Summit Trail Advisors first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Summit Trail Advisors's Galera Therapeutics, Inc. Common Stock position peaked at $20.7K in Q1 2024.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Summit Trail Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.